TNSN97048A1 - Pyridines 2 - aryl - substituees. - Google Patents
Pyridines 2 - aryl - substituees.Info
- Publication number
- TNSN97048A1 TNSN97048A1 TNTNSN97048A TNSN97048A TNSN97048A1 TN SN97048 A1 TNSN97048 A1 TN SN97048A1 TN TNSN97048 A TNTNSN97048 A TN TNSN97048A TN SN97048 A TNSN97048 A TN SN97048A TN SN97048 A1 TNSN97048 A1 TN SN97048A1
- Authority
- TN
- Tunisia
- Prior art keywords
- aryl
- pyridines
- substituted
- substituted pyridines
- pyridylaldehydes
- Prior art date
Links
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002902 organometallic compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
LES PYRIDINES 2-ARYL-SUBSTITUEES SONT PREPAREES PAR REACTION DE PYRIDYLALDEHYDES AVEC DES COMPOSES ORGANOMETALLIQUES, PUIS REDUCTION SELECTIVE DES PRODUITS. LES PYRIDINES 2-ARYL-SUBSTITUEES PEUVENT ETRE UTILISEES COMME PRINCIPES ACTIFS DANS DES MEDICAMENTS POUR LE TRAITEMENT DE L'ARTERIOSCLEROSE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19610932A DE19610932A1 (de) | 1996-03-20 | 1996-03-20 | 2-Aryl-substituierte Pyridine |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN97048A1 true TNSN97048A1 (fr) | 2005-03-15 |
Family
ID=7788843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN97048A TNSN97048A1 (fr) | 1996-03-20 | 1997-03-18 | Pyridines 2 - aryl - substituees. |
Country Status (30)
Country | Link |
---|---|
US (2) | US5925645A (fr) |
EP (1) | EP0796846B1 (fr) |
JP (1) | JPH09255574A (fr) |
AR (1) | AR006318A1 (fr) |
AT (1) | ATE194832T1 (fr) |
AU (1) | AU1628097A (fr) |
BG (1) | BG101339A (fr) |
BR (1) | BR9701348A (fr) |
CA (1) | CA2200175A1 (fr) |
CO (1) | CO4520282A1 (fr) |
CZ (1) | CZ84397A3 (fr) |
DE (2) | DE19610932A1 (fr) |
DK (1) | DK0796846T3 (fr) |
EE (1) | EE9700060A (fr) |
ES (1) | ES2150157T3 (fr) |
GR (1) | GR3034546T3 (fr) |
HR (1) | HRP970105A2 (fr) |
HU (1) | HUP9700610A1 (fr) |
ID (1) | ID16292A (fr) |
IL (1) | IL120468A0 (fr) |
MY (1) | MY132490A (fr) |
NO (1) | NO971269L (fr) |
NZ (1) | NZ314419A (fr) |
PL (1) | PL319050A1 (fr) |
PT (1) | PT796846E (fr) |
SG (1) | SG50805A1 (fr) |
SK (1) | SK36197A3 (fr) |
TN (1) | TNSN97048A1 (fr) |
TR (1) | TR199700213A2 (fr) |
ZA (1) | ZA972375B (fr) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
US6268392B1 (en) | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
AR008789A1 (es) * | 1996-07-31 | 2000-02-23 | Bayer Corp | Piridinas y bifenilos substituidos |
JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Cetp活性阻害剤として有効な化合物 |
DE19709125A1 (de) * | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
WO1999041237A1 (fr) * | 1998-02-13 | 1999-08-19 | G.D. Searle & Co. | Pyridines substituees utiles pour inhiber l'activite de la proteine assurant le transfert de l'ester de cholesteryle |
JP4546589B2 (ja) * | 1998-04-23 | 2010-09-15 | 武田薬品工業株式会社 | ナフタレン誘導体 |
GEP20094661B (en) * | 1998-09-25 | 2009-03-25 | Pharmacia Corp | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
US6462091B1 (en) | 1998-12-23 | 2002-10-08 | G.D. Searle & Co. | Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications |
US6489366B1 (en) | 1998-12-23 | 2002-12-03 | G. D. Searle, Llc | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
JP2002533414A (ja) | 1998-12-23 | 2002-10-08 | ジー.ディー.サール エルエルシー | 心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ |
IL143947A0 (en) | 1998-12-23 | 2002-04-21 | Searle Llc | Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
NZ512536A (en) | 1998-12-23 | 2003-11-28 | G | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
AU776664B2 (en) | 1998-12-23 | 2004-09-16 | G.D. Searle Llc | Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
ES2203239T3 (es) | 1998-12-23 | 2004-04-01 | G.D. Searle Llc | Combinaciones de inhibidores de la proteina de transferencia de ester de colesterilo y de agentes secuestrantes de acidos biliares para indicaciones cardiovasculares. |
US6521607B1 (en) * | 1999-09-23 | 2003-02-18 | Pharmacia Corporation | (R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
US6924313B1 (en) | 1999-09-23 | 2005-08-02 | Pfizer Inc. | Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
US6794544B2 (en) | 2000-03-10 | 2004-09-21 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
CA2450957A1 (fr) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Compositions pharmaceutiques de dispersions de medicaments et de polymeres neutres |
EP1269994A3 (fr) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Compositions Pharmaceutiques comprenant un médicament et un polymère permettant d'améliorer la concentration du médicament |
WO2003000238A1 (fr) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Compositions pharmaceutiques de produits d'adsorption de medicament amorphe |
US20040235877A1 (en) * | 2001-09-14 | 2004-11-25 | Natsuki Ishizuka | Novel use of tricyclic compound |
JP2005518347A (ja) | 2001-11-02 | 2005-06-23 | ジー.ディー. サール エルエルシー | 頂端ナトリウム共依存性胆汁酸輸送(asbt)およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物 |
MXPA04006255A (es) | 2002-01-17 | 2004-09-27 | Pharmacia Corp | Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato. |
JP2005523262A (ja) * | 2002-02-01 | 2005-08-04 | ファイザー・プロダクツ・インク | 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物 |
AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
DE60323536D1 (de) | 2002-12-20 | 2008-10-23 | Pfizer Prod Inc | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
KR20050110017A (ko) * | 2003-03-17 | 2005-11-22 | 니뽄 다바코 산교 가부시키가이샤 | S-'2-(''1-(2-에틸부틸)시클로헥실!카르보닐!아미노)페닐!-2-메틸프로판티오에이트의 경구 생체이용율을증가시키는 방법 |
PL1603553T3 (pl) * | 2003-03-17 | 2012-04-30 | Japan Tobacco Inc | Kompozycje farmaceutyczne inhibitorów CETP |
TWI393560B (zh) * | 2003-05-02 | 2013-04-21 | Japan Tobacco Inc | 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合 |
CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
JP2007501218A (ja) | 2003-08-04 | 2007-01-25 | ファイザー・プロダクツ・インク | 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物 |
SG146695A1 (en) | 2003-09-26 | 2008-10-30 | Japan Tobacco Inc | Method of inhibiting remnant lipoprotein production |
PE20050444A1 (es) * | 2003-10-31 | 2005-08-09 | Takeda Pharmaceutical | Compuestos de piridina como inhibidores de la peptidasa |
FR2873368B1 (fr) * | 2004-07-26 | 2008-01-04 | Merck Sante Soc Par Actions Si | Derives de guanidine et leurs utilisations en therapeutique |
EP1828137B1 (fr) * | 2004-12-18 | 2012-04-25 | Bayer Pharma Aktiengesellschaft | Dérivés de tétrahydrochinoline substituée par 4-cycloalkyle et leur utilisation comme médicaments |
WO2006082518A1 (fr) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Compositions pharmaceutiques a efficacite amelioree |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
BRPI0617621A2 (pt) | 2005-10-21 | 2011-08-02 | Novartis Ag | combinação de compostos orgánicos |
EP1815919A1 (fr) * | 2006-02-03 | 2007-08-08 | Uponor Innovation Ab | Fabrication d'un produit allongé |
DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
EP2379562A1 (fr) | 2008-12-16 | 2011-10-26 | Schering Corporation | Dérivés de pyranone bicyclique comme agonistes du récepteur de l'acide nicotinique |
EP2379547A1 (fr) | 2008-12-16 | 2011-10-26 | Schering Corporation | Dérivés de pyridopyrimidine et leurs procédés d'utilisation |
EP2516426B1 (fr) | 2009-12-21 | 2015-09-16 | Bayer CropScience AG | Bis(difluorométhyl)pyrazoles utilisés comme fongicides |
US8815775B2 (en) | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
EP3180335B1 (fr) | 2014-08-11 | 2021-05-05 | Angion Biomedica Corporation | Inhibiteurs de cytochrome p450 et leurs utilisations |
CA2970819A1 (fr) | 2014-12-31 | 2016-07-07 | Angion Biomedica Corp. | Methodes et agents pour traiter une maladie |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
ES2082755T3 (es) * | 1987-07-10 | 1996-04-01 | Hoechst Ag | Derivados de acido 3-desmetil-mevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su utilizacion asi como productos intermedios. |
US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
NO177005C (no) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
NZ230121A (en) * | 1988-08-29 | 1993-08-26 | Squibb & Sons Inc | Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels |
DE4244029A1 (de) * | 1992-12-24 | 1994-06-30 | Bayer Ag | Neue substituierte Pyridine |
-
1996
- 1996-03-20 DE DE19610932A patent/DE19610932A1/de not_active Withdrawn
-
1997
- 1997-02-25 HR HR19610932.9A patent/HRP970105A2/hr not_active Application Discontinuation
- 1997-03-07 EP EP97103813A patent/EP0796846B1/fr not_active Expired - Lifetime
- 1997-03-07 ES ES97103813T patent/ES2150157T3/es not_active Expired - Lifetime
- 1997-03-07 AT AT97103813T patent/ATE194832T1/de not_active IP Right Cessation
- 1997-03-07 DK DK97103813T patent/DK0796846T3/da active
- 1997-03-07 DE DE59702034T patent/DE59702034D1/de not_active Expired - Fee Related
- 1997-03-07 PT PT97103813T patent/PT796846E/pt unknown
- 1997-03-13 AU AU16280/97A patent/AU1628097A/en not_active Abandoned
- 1997-03-13 US US08/816,290 patent/US5925645A/en not_active Expired - Fee Related
- 1997-03-14 SG SG1997000783A patent/SG50805A1/en unknown
- 1997-03-17 JP JP9082454A patent/JPH09255574A/ja not_active Ceased
- 1997-03-17 IL IL12046897A patent/IL120468A0/xx unknown
- 1997-03-17 NZ NZ314419A patent/NZ314419A/xx unknown
- 1997-03-17 CA CA002200175A patent/CA2200175A1/fr not_active Abandoned
- 1997-03-18 TN TNTNSN97048A patent/TNSN97048A1/fr unknown
- 1997-03-18 BG BG101339A patent/BG101339A/xx unknown
- 1997-03-19 SK SK361-97A patent/SK36197A3/sk unknown
- 1997-03-19 CZ CZ97843A patent/CZ84397A3/cs unknown
- 1997-03-19 ZA ZA9702375A patent/ZA972375B/xx unknown
- 1997-03-19 HU HU9700610A patent/HUP9700610A1/hu unknown
- 1997-03-19 PL PL97319050A patent/PL319050A1/xx unknown
- 1997-03-19 BR BR9701348A patent/BR9701348A/pt not_active Application Discontinuation
- 1997-03-19 AR ARP970101096A patent/AR006318A1/es unknown
- 1997-03-19 NO NO971269A patent/NO971269L/no unknown
- 1997-03-19 MY MYPI97001168A patent/MY132490A/en unknown
- 1997-03-20 EE EE9700060A patent/EE9700060A/xx unknown
- 1997-03-20 ID IDP970913A patent/ID16292A/id unknown
- 1997-03-20 TR TR97/00213A patent/TR199700213A2/xx unknown
- 1997-03-20 CO CO97015054A patent/CO4520282A1/es unknown
-
1998
- 1998-12-21 US US09/217,214 patent/US6127383A/en not_active Expired - Fee Related
-
2000
- 2000-10-04 GR GR20000402236T patent/GR3034546T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA972375B (en) | 1997-09-25 |
DE19610932A1 (de) | 1997-09-25 |
BG101339A (en) | 1998-04-30 |
ES2150157T3 (es) | 2000-11-16 |
NO971269L (no) | 1997-09-22 |
MY132490A (en) | 2007-10-31 |
PL319050A1 (en) | 1997-09-29 |
NO971269D0 (no) | 1997-03-19 |
JPH09255574A (ja) | 1997-09-30 |
TR199700213A2 (xx) | 1997-10-21 |
ID16292A (id) | 1997-09-18 |
HRP970105A2 (en) | 1998-04-30 |
SK36197A3 (en) | 1997-11-05 |
GR3034546T3 (en) | 2001-01-31 |
EP0796846A1 (fr) | 1997-09-24 |
AU1628097A (en) | 1997-09-25 |
CO4520282A1 (es) | 1997-10-15 |
PT796846E (pt) | 2000-12-29 |
US5925645A (en) | 1999-07-20 |
DE59702034D1 (de) | 2000-08-24 |
IL120468A0 (en) | 1997-07-13 |
DK0796846T3 (da) | 2000-10-23 |
NZ314419A (en) | 1998-12-23 |
CA2200175A1 (fr) | 1997-09-20 |
US6127383A (en) | 2000-10-03 |
CZ84397A3 (en) | 1997-10-15 |
ATE194832T1 (de) | 2000-08-15 |
EP0796846B1 (fr) | 2000-07-19 |
HUP9700610A1 (hu) | 2000-08-28 |
AR006318A1 (es) | 1999-08-25 |
HU9700610D0 (en) | 1997-05-28 |
BR9701348A (pt) | 1998-11-10 |
EE9700060A (et) | 1997-10-15 |
SG50805A1 (en) | 1998-07-20 |
MX9702042A (es) | 1997-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN97048A1 (fr) | Pyridines 2 - aryl - substituees. | |
TNSN97117A1 (fr) | Pyridines heterocycliques condensees | |
CA2193337A1 (fr) | Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs | |
CA2180816A1 (fr) | 6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie | |
TNSN97116A1 (fr) | Pyridines bicycliques condensees | |
CA2149329A1 (fr) | Utilisation d'anticorps hybrides et radioisotopiques diriges contre l'antigene de restriction de la differenciation des lymphocytes b humains pour le traitement du lymphome b | |
UA42734C2 (uk) | Водорозчинна сіль німеcуліду, водний розчин солі німеcуліду, композиції на основі німеcуліду, спосіб отримання водорозчинної солі німеcуліду та фармацевтична композиція для лікування запалювальних захворювань | |
HK1047575A1 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same. | |
IL133655A0 (en) | Triazoline-thion-phosphoric acid derivatives | |
CA2254079A1 (fr) | Derives de l'androstene | |
TNSN96007A1 (fr) | Purine - 6 - ones 2,9 - disubstituees | |
EP0147146A3 (fr) | Accroissement de l'absorption percutanée d'un médicament | |
BE900564A (fr) | Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. | |
DZ3160A1 (fr) | Composition renfermant de la sphingomyelinase alcaline utilisee comme préparation diététique, complement alimentaire ou produit pharmaceutique. | |
DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
TNSN97061A1 (fr) | NOUVEAUX PYRIMIDO [1,2 – a ] INDOLES. | |
FR2794976B1 (fr) | Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane | |
TNSN96016A1 (fr) | Utilisation de phenylcyclohexylcarboxamides | |
AU3808795A (en) | Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal product and their intended use in anticancer treatments | |
AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments | |
ITMI922742A0 (it) | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
MXPA01007210A (es) | Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo. | |
ZA968762B (en) | Derivatives of acid pyrazoles, their preparation process, their use as medicaments, their new use and the pharmaceutical compositions containing them. | |
HUP0103623A3 (en) | Bispiperidines as antithrombotic agents, their process for preparation and medicament containing them as active ingredient | |
SI0805817T1 (fr) |